Literature DB >> 10543882

New natural sesquiterpenes as modulators of daunomycin resistance in a multidrug-resistant Leishmania tropica line.

J M Pérez-Victoria1, B M Tincusi, I A Jiménez, I L Bazzocchi, M P Gupta, S Castanys, F Gamarro, A G Ravelo.   

Abstract

The effects produced by nine dihydro-beta-agarofuran sesquiterpenes isolated from Crossopetalum tonduzii (1-8) and Maytenus macrocarpa (9) (Celastraceae) on the reversion of the resistant phenotype on a multidrug-resistant Leishmania line and their binding to recombinant C-terminal nucleotide-binding domain of Leishmania P-glycoprotein-like transporter were studied. The structures of the new compounds (1-5) were elucidated by spectroscopic methods, including (1)H-(13)C heteronuclear correlation (HMQC), long-range correlation spectra with inversal detection (HMBC), ROESY experiments, and chemical correlations. The absolute configuration of one of them (1) was determined by CD studies. The structure-activity relationship is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543882     DOI: 10.1021/jm991066b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Isolation, biological evaluation and 3D-QSAR studies of insecticidal/narcotic sesquiterpene polyol esters.

Authors:  Shao-peng Wei; Zhi-qin Ji; Hui-xiao Zhang; Ji-wen Zhang; Yong-hua Wang; Wen-jun Wu
Journal:  J Mol Model       Date:  2010-06-08       Impact factor: 1.810

2.  Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux.

Authors:  José M Pérez-Victoria; Fernando Cortés-Selva; Adriana Parodi-Talice; Boris I Bavchvarov; F Javier Pérez-Victoria; Francisco Muñoz-Martínez; Mathias Maitrejean; M Paola Costi; Denis Barron; Attilio Di Pietro; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin.

Authors:  J M Pérez-Victoria; F J Pérez-Victoria; G Conseil; M Maitrejean; G Comte; D Barron; A Di Pietro; S Castanys; F Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Oppositines A and B, sesquiterpene pyridine alkaloids from a Sri Lankan Pleurostylia opposita.

Authors:  Emily L Whitson; S M V Damayanthi Mala; Charles A Veltri; Tim S Bugni; E Dilip de Silva; Chris M Ireland
Journal:  J Nat Prod       Date:  2006-12       Impact factor: 4.050

5.  Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.

Authors:  José M Pérez-Victoria; Boris I Bavchvarov; Iván R Torrecillas; Marta Martínez-García; Carmen López-Martín; Mercedes Campillo; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

6.  Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator.

Authors:  J M Pérez-Victoria; F J Pérez-Victoria; A Parodi-Talice; I A Jiménez; A G Ravelo; S Castanys; F Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Semisynthesis and antifeedant activity of new derivatives of a dihydro-β-agarofuran from Parnassia wightiana.

Authors:  Jiang-Jiang Tang; Fei-Yu Zhang; Dong-Mei Wang; Jun-Mian Tian; Shuai Dong; Jin-Ming Gao
Journal:  Int J Mol Sci       Date:  2013-09-26       Impact factor: 5.923

Review 8.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.